Overview

Diclophenac Versus Placebo for Pain Control in Diagnostic Colonoscopy

Status:
Completed
Trial end date:
2016-10-01
Target enrollment:
Participant gender:
Summary
Patients will be randomized to receive diclophenac sodium or placebo two hours before diagnostic colonoscopy. Intensity of pain as measured on a 10-point Likert scale will be the primary outcome. Patients will be followed until hospital discharge, an average of 10 days.
Phase:
Phase 3
Details
Lead Sponsor:
University Hospital Rijeka
Treatments:
Diclofenac